Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

ETON holding history

Eton Pharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ETON overviewAll 13F holders of ETONFull Q2 2026 holdings

Shares (Q2 2026)
767,972
Value
$27.8M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ETON by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026767,972$27.8M<0.1%+290,015+60.7%AddedHolders
Q1 2026477,957$11.8M<0.1%−15,957−3.2%ReducedHolders
Q4 2025493,914$8.35M<0.1%−92,132−15.7%ReducedHolders
Q3 2025586,046$12.7M<0.1%+76,478+15.0%AddedHolders
Q2 2025509,568$7.26M<0.1%+362,236+245.9%AddedHolders
Q1 2025147,332$1.91M<0.1%+134,139+1,016.7%AddedHolders
Q4 202413,193$175.7K<0.1%+12,721+2,695.1%AddedHolders
Q3 2024472$2.83K<0.1%+280+145.8%AddedHolders
Q2 2024192$632<0.1%+154+405.3%AddedHolders
Q1 202438$143<0.1%00.0%UnchangedHolders
Q4 202338$166<0.1%−58−60.4%ReducedHolders
Q3 202396$400<0.1%−748−88.6%ReducedHolders
Q2 2023844$2.95K<0.1%−1,860−68.8%ReducedHolders
Q1 20232,704$10.4K<0.1%−5,437−66.8%ReducedHolders
Q4 20228,141$23.0K<0.1%+1,391+20.6%AddedHolders
Q3 20226,750$14.0K<0.1%−1,685−20.0%ReducedHolders
Q2 20228,435$23.0K<0.1%−19,636−70.0%ReducedHolders
Q1 202228,071$122.0K<0.1%−2,001−6.7%ReducedHolders
Q4 202130,072$129.0K<0.1%−4,677−13.5%ReducedHolders
Q3 202134,749$175.0K<0.1%+33,159+2,085.5%AddedHolders
Q2 20211,590$10.0K<0.1%−644−28.8%ReducedHolders
Q1 20212,234$17.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.